$22.41
-0.44 (-1.93%)
Open$23.21
Previous Close$22.85
Day High$23.43
Day Low$21.95
52W High$38.33
52W Low$4.95
Volume—
Avg Volume985.3K
Market Cap1.73B
P/E Ratio—
EPS$-12.01
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.65M | 7.80M | 6.88M |
| Net Income | -2,097,514 | -1,645,262 | -1,540,052 |
| Profit Margin | -27.4% | -21.1% | -22.4% |
| EBITDA | -2,154,773 | -2,236,853 | -1,912,817 |
| Free Cash Flow | -1,120,093 | -988,846 | -1,121,747 |
| Rev Growth | +8.4% | +22.8% | +24.7% |
| Debt/Equity | 0.85 | 0.67 | 0.79 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |